Annual EBIT
-$67.10 M
-$34.45 M-105.48%
31 December 2023
Summary:
Acrivon Therapeutics Common Stock annual earnings before interest & taxes is currently -$67.10 million, with the most recent change of -$34.45 million (-105.48%) on 31 December 2023. During the last 3 years, it has fallen by -$63.94 million (-2018.15%). ACRV annual EBIT is now -2018.15% below its all-time high of -$3.15 million.ACRV EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$25.14 M
-$3.70 M-17.27%
30 September 2024
Summary:
Acrivon Therapeutics Common Stock quarterly earnings before interest & taxes is currently -$25.14 million, with the most recent change of -$3.70 million (-17.27%) on 30 September 2024. Over the past year, it has dropped by -$9.00 million (-55.79%). ACRV quarterly EBIT is now -841.22% below its all-time high of -$2.67 million, reached on 01 September 2021.ACRV Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$85.30 M
-$9.00 M-11.80%
30 September 2024
Summary:
Acrivon Therapeutics Common Stock TTM earnings before interest & taxes is currently -$85.30 million, with the most recent change of -$9.00 million (-11.80%) on 30 September 2024. Over the past year, it has dropped by -$29.30 million (-52.33%). ACRV TTM EBIT is now -3093.49% below its all-time high of -$2.67 million, reached on 01 September 2021.ACRV TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRV EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -105.5% | -55.8% | -52.3% |
| 3 y3 years | -2018.2% | -488.8% | -1128.9% |
| 5 y5 years | - | - | - |
ACRV EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -2018.2% | at low | -488.8% | at low | -1128.9% | at low |
| 5 y | 5 years | -2018.2% | at low | -841.2% | at low | -3093.5% | at low |
| alltime | all time | -2018.2% | at low | -841.2% | at low | -3093.5% | at low |
Acrivon Therapeutics Common Stock EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$25.14 M(+17.3%) | -$85.30 M(+11.8%) |
| June 2024 | - | -$21.44 M(+21.3%) | -$76.30 M(+8.4%) |
| Mar 2024 | - | -$17.67 M(-16.1%) | -$70.38 M(+4.9%) |
| Dec 2023 | -$67.10 M(+105.5%) | -$21.05 M(+30.5%) | -$67.10 M(+19.8%) |
| Sept 2023 | - | -$16.14 M(+4.0%) | -$55.99 M(+13.3%) |
| June 2023 | - | -$15.52 M(+7.8%) | -$49.43 M(+24.1%) |
| Mar 2023 | - | -$14.39 M(+44.7%) | -$39.84 M(+22.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$32.66 M(+101.8%) | -$9.95 M(+3.9%) | -$32.66 M(+21.0%) |
| Sept 2022 | - | -$9.57 M(+61.6%) | -$26.98 M(+34.4%) |
| June 2022 | - | -$5.92 M(-17.8%) | -$20.08 M(+41.9%) |
| Mar 2022 | - | -$7.21 M(+68.9%) | -$14.15 M(+103.9%) |
| Dec 2021 | -$16.18 M(+410.9%) | - | - |
| Dec 2021 | - | -$4.27 M(+59.9%) | -$6.94 M(+159.9%) |
| Sept 2021 | - | -$2.67 M | -$2.67 M |
| Dec 2020 | -$3.17 M | - | - |
FAQ
- What is Acrivon Therapeutics Common Stock annual earnings before interest & taxes?
- What is the all time high annual EBIT for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock annual EBIT year-on-year change?
- What is Acrivon Therapeutics Common Stock quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock quarterly EBIT year-on-year change?
- What is Acrivon Therapeutics Common Stock TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock TTM EBIT year-on-year change?
What is Acrivon Therapeutics Common Stock annual earnings before interest & taxes?
The current annual EBIT of ACRV is -$67.10 M
What is the all time high annual EBIT for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high annual earnings before interest & taxes is -$3.15 M
What is Acrivon Therapeutics Common Stock annual EBIT year-on-year change?
Over the past year, ACRV annual earnings before interest & taxes has changed by -$34.45 M (-105.48%)
What is Acrivon Therapeutics Common Stock quarterly earnings before interest & taxes?
The current quarterly EBIT of ACRV is -$25.14 M
What is the all time high quarterly EBIT for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high quarterly earnings before interest & taxes is -$2.67 M
What is Acrivon Therapeutics Common Stock quarterly EBIT year-on-year change?
Over the past year, ACRV quarterly earnings before interest & taxes has changed by -$9.00 M (-55.79%)
What is Acrivon Therapeutics Common Stock TTM earnings before interest & taxes?
The current TTM EBIT of ACRV is -$85.30 M
What is the all time high TTM EBIT for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high TTM earnings before interest & taxes is -$2.67 M
What is Acrivon Therapeutics Common Stock TTM EBIT year-on-year change?
Over the past year, ACRV TTM earnings before interest & taxes has changed by -$29.30 M (-52.33%)